Journal articlesUsing TLC-NOSF advanced wound dressing to improve outcomes for patients with leg and diabetic foot ulcers

Using TLC-NOSF advanced wound dressing to improve outcomes for patients with leg and diabetic foot ulcers

07/11/17 | Diabetic foot ulcers, Leg Ulcers, Wellbeing and concordance | Caroline Dowsett

Healthcare providers are under pressure to balance cost of care with the delivery of high-quality patient outcomes. Breaking the cycle of hard-to-heal wounds requires a proactive approach that includes recognising and understanding the extent of the problem, and early intervention using advanced wound technologies that improve healing rates, reduce clinical time, avoid hospital admission and improve patient satisfaction. There is evidence that some advanced wound dressings are effective in improving healing rates when used as part of a holistic approach to leg and diabetic foot ulcer management, contributing to improved patient outcomes and more effective use of resources. This article reviews the use of technology lipido-colloid nano-oligosaccharide factor (TLC-NOSF) and the evidence for its use.